576 related articles for article (PubMed ID: 16581031)
1. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.
Moore H; Jentsch JD; Ghajarnia M; Geyer MA; Grace AA
Biol Psychiatry; 2006 Aug; 60(3):253-64. PubMed ID: 16581031
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in behaviour, histology and prefrontal cortical gene expression profiles relevant to schizophrenia in embryonic day 17 MAM-Exposed C57BL/6 mice.
Huo C; Liu X; Zhao J; Zhao T; Huang H; Ye H
Neuropharmacology; 2018 Sep; 140():287-301. PubMed ID: 30056124
[TBL] [Abstract][Full Text] [Related]
3. Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.
Gill KM; Miller SA; Grace AA
Schizophr Res; 2018 May; 195():343-352. PubMed ID: 28927551
[TBL] [Abstract][Full Text] [Related]
4. [MAM-E17 schizophrenia rat model].
Kállai V; Tóth A; Gálosi R; Szabó I; Petykó Z; Karádi Z; Kállai J; Lénárd L
Psychiatr Hung; 2015; 30(1):4-17. PubMed ID: 25867884
[TBL] [Abstract][Full Text] [Related]
5. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia.
Penschuck S; Flagstad P; Didriksen M; Leist M; Michael-Titus AT
Eur J Neurosci; 2006 Jan; 23(1):279-84. PubMed ID: 16420437
[TBL] [Abstract][Full Text] [Related]
6. Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia.
Featherstone RE; Rizos Z; Nobrega JN; Kapur S; Fletcher PJ
Neuropsychopharmacology; 2007 Feb; 32(2):483-92. PubMed ID: 17035930
[TBL] [Abstract][Full Text] [Related]
7. The prenatal methylazoxymethanol acetate treatment: a neurodevelopmental animal model for schizophrenia?
Jongen-Rêlo AL; Leng A; Lüber M; Pothuizen HH; Weber L; Feldon J
Behav Brain Res; 2004 Mar; 149(2):159-81. PubMed ID: 15129780
[TBL] [Abstract][Full Text] [Related]
8. Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult.
O'Reilly KC; Perica MI; Fenton AA
Neurobiol Learn Mem; 2016 Oct; 134 Pt B(Pt B):294-303. PubMed ID: 27485950
[TBL] [Abstract][Full Text] [Related]
9. Nicotinic modulation of auditory evoked potential electroencephalography in a rodent neurodevelopmental model of schizophrenia.
Kohlhaas KL; Robb HM; Roderwald VA; Rueter LE
Biochem Pharmacol; 2015 Oct; 97(4):482-487. PubMed ID: 26032639
[TBL] [Abstract][Full Text] [Related]
10. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
Gomes FV; Guimarães FS; Grace AA
Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and cognitive impairments observed in animal models of schizophrenia induced by prenatal stress paradigm or methylazoxymethanol acetate administration.
Ratajczak P; Kus K; Murawiecka P; Słodzińska I; Giermaziak W; Nowakowska E
Acta Neurobiol Exp (Wars); 2015; 75(3):314-25. PubMed ID: 26581387
[TBL] [Abstract][Full Text] [Related]
12. The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus.
Hradetzky E; Sanderson TM; Tsang TM; Sherwood JL; Fitzjohn SM; Lakics V; Malik N; Schoeffmann S; O'Neill MJ; Cheng TM; Harris LW; Rahmoune H; Guest PC; Sher E; Collingridge GL; Holmes E; Tricklebank MD; Bahn S
Neuropsychopharmacology; 2012 Jan; 37(2):364-77. PubMed ID: 21956444
[TBL] [Abstract][Full Text] [Related]
13. Prenatal disruption of neocortical development alters prefrontal cortical neuron responses to dopamine in adult rats.
Lavin A; Moore HM; Grace AA
Neuropsychopharmacology; 2005 Aug; 30(8):1426-35. PubMed ID: 15827574
[TBL] [Abstract][Full Text] [Related]
14. Aberrant high frequency oscillations recorded in the rat nucleus accumbens in the methylazoxymethanol acetate neurodevelopmental model of schizophrenia.
Goda SA; Olszewski M; Piasecka J; Rejniak K; Whittington MA; Kasicki S; Hunt MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Aug; 61():44-51. PubMed ID: 25862088
[TBL] [Abstract][Full Text] [Related]
15. MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs.
Mar AC; Nilsson SRO; Gamallo-Lana B; Lei M; Dourado T; Alsiö J; Saksida LM; Bussey TJ; Robbins TW
Psychopharmacology (Berl); 2017 Oct; 234(19):2837-2857. PubMed ID: 28744563
[TBL] [Abstract][Full Text] [Related]
16. Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol.
Le Pen G; Jay TM; Krebs MO
J Psychopharmacol; 2011 Jun; 25(6):822-35. PubMed ID: 21088043
[TBL] [Abstract][Full Text] [Related]
17. Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies.
Potasiewicz A; Holuj M; Litwa E; Gzielo K; Socha L; Popik P; Nikiforuk A
Neuropharmacology; 2020 Jun; 170():108040. PubMed ID: 32165218
[TBL] [Abstract][Full Text] [Related]
18. Effect of estrous cycle on schizophrenia-like behaviors in MAM exposed rats.
Perez SM; Donegan JJ; Lodge DJ
Behav Brain Res; 2019 Apr; 362():258-265. PubMed ID: 30660776
[TBL] [Abstract][Full Text] [Related]
19. Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia.
Chin CL; Curzon P; Schwartz AJ; O'Connor EM; Rueter LE; Fox GB; Day M; Basso AM
Synapse; 2011 May; 65(5):393-403. PubMed ID: 20803618
[TBL] [Abstract][Full Text] [Related]
20. Prenatal methylazoxymethanol acetate alters behavior and brain NGF levels in young rats: a possible correlation with the development of schizophrenia-like deficits.
Fiore M; Talamini L; Angelucci F; Koch T; Aloe L; Korf J
Neuropharmacology; 1999 Jun; 38(6):857-69. PubMed ID: 10465689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
